High-yield reassortant virus containing hemagglutinin and neuraminidase genes of pandemic influenza A/Moscow/01/2009 (H1N1) virus

Voprosy Virusologii

Volumn 56, Issue 4, 2011, Pages 9-14

  Ignatieva, A V ^a   Rudneva, I A ^a   Timofeeva, T A ^a   Shilov, A A ^a   Zaberezhnyi, A D ^a   Aliper, T I ^a   Kaverin, N V ^a   Lvov, D K ^a  

^a N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

Author keywords

Hemagglutinin; Influenza virus; Neuraminidase; Pandemic; Reassortant

Indexed keywords

MUS; ORTHOMYXOVIRIDAE;

EID: 80052225279     PISSN: 05074088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Belser J. A., WadfordJ. A., Pappas C. et al. Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (HI) viruses in mice // J. Virol. - 2010. - Vol. 84. - P. 4194-4203.
2. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding // Anal. Biochem. - 1976. - Vol. 72. - P. 248-254.
3. Chen Z., Wang W., Zhou H. et al. Generation of live attenuated novel influenza virus A/California/07/2009 (H1N1) vaccines with high yield in embryonated chicken eggs // J. Virol. - 2010. - Vol. 84. - P. 44-51.
4. Dawood F. S., Jain S., Finelli L. et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans // N. Engl. J. Med. - 2009. - Vol. 360. - P. 2605-2615.
5. DingX., Jiang L, Ke C. et al. Amino acid sequence analysis and identification of mutations under positive selection in hemagglutinin of 2009 influenza A (H1N1) isolates // Virus Genes. - Vol. 41. - P. 329-340.
6. Eraser C, Donelly C. A., Cauchemez S. et al. Pandemic potential of a strain of influenza A (H1N1): early findings // Science. - - Vol. 324. - P. 1557-1561.
7. Garten R. J., Davis C. T., Russell C. A. et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans // Science. - 2009. - Vol. 325. - P. 197-201.
8. Hoffmann E., Neumann G., Kawaoka Y. et al. A DNA transfection system for generation of influenza A virus from eight plasmids // Proc. Natl. Acad. Sci. USA. - 2000. - Vol. 97. - P. 6108-6113. (Pubitemid 30367531)
9. Hoffmann E., Lipatov A. S., Webby R. G. et al. Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines // Proc. Natl. Acad. Sci. USA. - 2005. - Vol. 102. - P. 12915-12920. (Pubitemid 41279464)
10. Ilyushina N. A., Khalenkov A. M., Seller J. P. et al. H1N1 influenza viruses in mice // J. Virol. - 2010. - Vol. 84. - P. 8607-8616.
11. KalthoffD., Grund C, Harder T. C. et al. Limited susceptibility of chickens, turkeys, and mice to pandemic (H1N1) 2009 virus // Emerg. Infect. Dis. - 2010. - Vol. 16. - P. 703-705.
12. Kilboume E. D., Schulman J. L., Schild G. C. et al. Related studies of a recombinant influenza-virus vaccine. I. Derivation and characterization of virus and vaccine // J. Infect. Dis. - - Vol. 124. - P. 449-462.
13. Kingsford C, Nagarajan N., SalzbergS. L. 2009 Swine origin influenza A(H1N1) resembles previous influenza isolates // PloS One. - 2009. - Vol. 4. - P. 1-6.
14. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4 // Nature. - 1970. - Vol. 227. - P. 680-685.
15. Lipatov A. S., Govorkova E. A., Webby A. J. Influenza: Emergence and control // J. Virol. - 2004. - Vol. 78. - P. 8951-8959.
16. Lowry O. H, Rosenbrough N. J., Fair A. L., Randall R. J. Protein measurement with the Folin phenol reagent // J. Biol. Chem. - 1951. - Vol. 193. - P. 263-275.
17. Melidou A., Gioula G., Exindari M. et al. Molecular and phylogenetic analysis of the haemagglutinin gene of pandemic influenza H1N1 2009 viruses associated with severe and fatal infections // Virus Res. - 2010. - Vol. 151. - P. 192-199.
18. Neumann G., Noda T., Kawaoka Y. Emergence and pandemic potential of swine origin H1N1 influenza virus // Nature. - - Vol. 459. - P. 931-939.
19. Philpott M., Easterday B. C, Hinshaw V. S. Neutralizing epitopes of the H5 hemagglutinin from a virulent avian influenza virus and their relationship to pathogenicity // J. Virol. - - Vol. 63. - P. 3453-3458.
20. Rudneva I. A., Kovaleva V. P., Varich N. L. et al. Influenza A virus reassortants with surface glycoprotein genes of the avian parent viruses: effects of HA and NA gene combinations on virus aggregation//Arch. Virol. - 1993. - Vol. 133. - P. 437-450. (Pubitemid 2016440)
21. Rudneva I. A., Sklyanskaya E. I., Barulina O. S. et al. Phenotypic expression of HA-NA combinations in human-avian influenza A virus reassortants // Arch. Virol. - 1996. - Vol. 141. - P. 1091-1099. (Pubitemid 26312539)
22. Rudneva I. A., Timofeeva T. A., Shilov A. A. et al. Effect of gene constellation and postreassortment amino acid change on the phenotypic features of H5 influenza virus reassortants // Arch. Virol. - 2007. - Vol. 152. - P. 1139-1145. (Pubitemid 46800709)
23. Schulman J. L., Palese P. Selection and identification of influenza virus recombinants of defined genetic composition // J. Virol. - 1976. - Vol. 20. - P. 248-254.
24. Smith J., Vijayakrishna D., Bahl J. et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic // Nature. - 2009. - Vol. 459. - P. 1122-1126.
25. Suphaphiphat P., Franti M., Hekele A. et al. Mutations at positions 186 and 194 in the HA gene of the 2009 H1N1 pandemic influenza virus improve replication in cell culture and eggs // Virol. J. - 2010. - Vol. 7. - P. 157.
26. Wanitchang A., Kramyu J., Jongkaewwattana A. Enhancement of reverse genetics-derived swine-origin H1N1 influenza virus seed vaccine growth by inclusion of indigenous polymerase PB1 protein // Virus Res. - 2010. - Vol. 147. - P. 145-148.
27. Webby R. J., Perez D. R., Coleman J. S. et al. Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines // Lancet. - 2004. - Vol. 363. - P. 1099-1103. (Pubitemid 38452781)
28. Zhang W. Candidate pandemic H1N1 vaccine viruses and vaccine potency reagents // Extraordinary Meeting of SAGE July 7, 2009, Geneva, WHO. http://www.who.int/entity/immunization/sage/W.Zhang-SAGE-vaccine-virus-reagents- Final.pd7